Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C16H21N3O2 |
Molecular Weight | 287.3568 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C)CCC1=CNC2=C1C=C(C[C@@H]3COC(=O)N3)C=C2
InChI
InChIKey=ULSDMUVEXKOYBU-CYBMUJFWSA-N
InChI=1S/C16H21N3O2/c1-19(2)6-5-12-9-17-15-4-3-11(8-14(12)15)7-13-10-21-16(20)18-13/h3-4,8-9,13,17H,5-7,10H2,1-2H3,(H,18,20)/t13-/m1/s1
Molecular Formula | C16H21N3O2 |
Molecular Weight | 287.3568 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Sumatriptan: pharmacological basis and clinical results. | 2001 |
|
New abortive agents for the treatment of migraine. | 2001 |
|
Sumatriptan, 5-HT(1D) receptors and obsessive-compulsive disorder. | 2001 Apr |
|
[Current topics: expectation for new triptans]. | 2001 Apr 10 |
|
Serotonergic effects and extracellular brain levels of eletriptan, zolmitriptan and sumatriptan in rat brain. | 2001 Aug 17 |
|
A systematic review of the use of triptans in acute migraine. | 2001 Feb |
|
What is the optimal strategy for managing acute migraine headaches? | 2001 Feb |
|
NMR studies on three optical active drug molecules. | 2001 Jan-Feb |
|
An open preference study with sumatriptan 50 mg and zolmitriptan 2.5 mg in 100 migraine patients. | 2001 Jul |
|
Safety and rational use of the triptans. | 2001 Jul |
|
Molecular cloning, pharmacological properties and tissue distribution of the porcine 5-HT(1B) receptor. | 2001 Jul |
|
Establishing a standard of speed for assessing the efficacy of the serotonin(1B/1D) agonists (triptans). | 2001 Jul |
|
Migraine treatment outcomes with rizatriptan in triptan-naive patients: a naturalistic study. | 2001 Jun |
|
Current options for the prevention and treatment of migraine. | 2001 Jun |
|
Recent development in paediatric headache. | 2001 Jun |
|
Donitriptan (Pierre Fabre). | 2001 Mar |
|
Zolmitriptan versus sumatriptan comparison trial. | 2001 Mar |
|
4991W93 inhibits release of calcitonin gene-related peptide in the cat but only at doses with 5HT(1B/1D) receptor agonist activity? | 2001 Mar |
|
Effect of MAO-A inhibition on the pharmacokinetics of almotriptan, an antimigraine agent in humans. | 2001 May |
|
Decreased sensitivity of 5-HT(1D) receptors in melancholic depression. | 2001 May |
|
Zolmitriptan versus sumatriptan for the acute oral treatment of migraine: a randomized, double-blind, international study. | 2001 May |
|
Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. | 2001 Nov 17 |
|
Zolmitriptan--a 5-HT1B/D agonist, alcohol, and aggression in mice. | 2001 Sep |
|
Dexamethasone decreases migraine recurrence observed after treatment with a triptan combined with a nonsteroidal anti-inflammatory drug. | 2001 Sep |
|
Effect of rizatriptan and other triptans on the nausea symptom of migraine: a post hoc analysis. | 2001 Sep |
|
What matters is not the differences between triptans, but the differences between patients. | 2001 Sep |
|
Triptans are all different. | 2001 Sep |
|
Have the triptans fulfilled their promise? | 2001 Sep |
|
Rizatriptan: an update of its use in the management of migraine. | 2002 |
|
Selegiline: a second look. Six years later: too risky in Parkinson's disease. | 2002 Aug |
|
Comparison of triptan tablet consumption per attack: a prospective study of migraineurs in Spain. | 2002 Feb |
|
[Treatment of migraine in patients with hypertension and ischemic heart disease]. | 2002 Jan 20 |
|
The pharmacokinetics of the antimigraine compound zolmitriptan in Japanese and Caucasian subjects. | 2002 Jul |
|
Mechanisms of action of the 5-HT1B/1D receptor agonists. | 2002 Jul |
|
Gateways to Clinical Trials. June 2002. | 2002 Jun |
|
Zolmitriptan is effective and well tolerated in Japanese patients with migraine: a dose-response study. | 2002 Jun |
|
Efficacy of oral ketoprofen in acute migraine: a double-blind randomized clinical trial. | 2002 Jun 11 |
|
Newer formulations of the triptans: advances in migraine management. | 2003 |
|
Tolerability and consistency of effect of zolmitriptan nasal spray in a long-term migraine treatment trial. | 2003 |
|
Management of trigeminal autonomic cephalgias and hemicrania continua. | 2003 |
|
Transcranial Doppler in migraine attacks before and after treatment with oral zolmitriptan or sumatriptan. | 2003 Jan |
|
Coprescription of triptans with potentially interacting medications: a cohort study involving 240,268 patients. | 2003 Jan |
|
Migraine prevalence and treatment patterns: the global Migraine and Zolmitriptan Evaluation survey. | 2003 Jan |
|
Eletriptan metabolism by human hepatic CYP450 enzymes and transport by human P-glycoprotein. | 2003 Jul |
|
The evolving management of migraine. | 2003 Jun |
|
Safety profile of the triptans. | 2003 Mar |
|
[Highly selective beginning. Associated symptoms and side effects in retrospect]. | 2003 May 26 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:48:02 GMT 2023
by
admin
on
Sat Dec 16 10:48:02 GMT 2023
|
Record UNII |
F3YOE57701
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
F3YOE57701
Created by
admin on Sat Dec 16 10:48:02 GMT 2023 , Edited by admin on Sat Dec 16 10:48:02 GMT 2023
|
PRIMARY | |||
|
1727018
Created by
admin on Sat Dec 16 10:48:02 GMT 2023 , Edited by admin on Sat Dec 16 10:48:02 GMT 2023
|
PRIMARY | |||
|
139264-24-7
Created by
admin on Sat Dec 16 10:48:02 GMT 2023 , Edited by admin on Sat Dec 16 10:48:02 GMT 2023
|
PRIMARY | |||
|
441240
Created by
admin on Sat Dec 16 10:48:02 GMT 2023 , Edited by admin on Sat Dec 16 10:48:02 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|